Bumrungrad Hospital (BH) Q2 2026 Pre-recorded earnings summary

Executive summary

• Revenue and profit increased both quarter-over-quarter and year-over-year for the three- and six-month periods ended 30 June 2026.

• Strong cash flow from operations, but significant cash outflows for dividends and investments led to a decrease in cash balances.

• Auditor review found no material misstatements in the interim financial information.

Financial highlights

• Three-month consolidated revenue: THB 6,278 million, up from THB 6,104 million year-over-year.

• Three-month net profit: THB 1,910 million, up from THB 1,880 million year-over-year.

• Six-month consolidated revenue: THB 12,532 million, up from THB 12,310 million year-over-year.

• Six-month net profit: THB 3,710 million, up from THB 3,623 million year-over-year.

• Basic EPS for six months: THB 4.63, up from THB 4.52 year-over-year.

Outlook and guidance

• Interim dividend of THB 4 per share (THB 3,183 million) approved for payment in September 2026.